COVID-19 Impact on Prescription Dermatology Therapeutics Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Prescription Dermatology Therapeutics Industry
1.7 COVID-19 Impact: Prescription Dermatology Therapeutics Market Trends
2 Global Prescription Dermatology Therapeutics Quarterly Market Size Analysis
2.1 Prescription Dermatology Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Prescription Dermatology Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Prescription Dermatology Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Prescription Dermatology Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Prescription Dermatology Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Prescription Dermatology Therapeutics Market
3.4 Key Players Prescription Dermatology Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Prescription Dermatology Therapeutics Segments, By Type
4.1 Introduction
1.4.1 Fungal Infection Drugs
1.4.2 Skin Cancer Drugs
1.4.3 Acne & Rosacea Drugs
1.4.4 Psoriasis Drugs
1.4.5 Dermatitis & Seborrhea Drugs
4.2 By Type, Global Prescription Dermatology Therapeutics Market Size, 2019-2021
5 Impact of Covid-19 on Prescription Dermatology Therapeutics Segments, By Application
5.1 Overview
5.5.1 Hospital Pharmacies
5.5.2 Retail Pharmacies
5.5.3 Online Pharmacies
5.2 By Application, Global Prescription Dermatology Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Prescription Dermatology Therapeutics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.1.3 Pfizer Prescription Dermatology Therapeutics Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 AbbVie
7.2.1 AbbVie Business Overview
7.2.2 AbbVie Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.2.3 AbbVie Prescription Dermatology Therapeutics Product Introduction
7.2.4 AbbVie Response to COVID-19 and Related Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Business Overview
7.3.2 Johnson & Johnson Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Product Introduction
7.3.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.4 Novartis
7.4.1 Novartis Business Overview
7.4.2 Novartis Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.4.3 Novartis Prescription Dermatology Therapeutics Product Introduction
7.4.4 Novartis Response to COVID-19 and Related Developments
7.5 Amgen
7.5.1 Amgen Business Overview
7.5.2 Amgen Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.5.3 Amgen Prescription Dermatology Therapeutics Product Introduction
7.5.4 Amgen Response to COVID-19 and Related Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Business Overview
7.6.2 Eli Lilly Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.6.3 Eli Lilly Prescription Dermatology Therapeutics Product Introduction
7.6.4 Eli Lilly Response to COVID-19 and Related Developments
7.7 Celgene
7.7.1 Celgene Business Overview
7.7.2 Celgene Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.7.3 Celgene Prescription Dermatology Therapeutics Product Introduction
7.7.4 Celgene Response to COVID-19 and Related Developments
7.8 LEO Pharma
7.8.1 LEO Pharma Business Overview
7.8.2 LEO Pharma Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.8.3 LEO Pharma Prescription Dermatology Therapeutics Product Introduction
7.8.4 LEO Pharma Response to COVID-19 and Related Developments
7.9 Bausch Health Companies
7.9.1 Bausch Health Companies Business Overview
7.9.2 Bausch Health Companies Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Product Introduction
7.9.4 Bausch Health Companies Response to COVID-19 and Related Developments
7.10 Sun Pharmaceutical
7.10.1 Sun Pharmaceutical Business Overview
7.10.2 Sun Pharmaceutical Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Product Introduction
7.10.4 Sun Pharmaceutical Response to COVID-19 and Related Developments
7.11 Aclaris Therapeutics
7.11.1 Aclaris Therapeutics Business Overview
7.11.2 Aclaris Therapeutics Prescription Dermatology Therapeutics Quarterly Revenue, 2020
7.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Product Introduction
7.11.4 Aclaris Therapeutics Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Prescription Dermatology Therapeutics Assessment
Table 9. COVID-19 Impact: Prescription Dermatology Therapeutics Market Trends
Table 10. COVID-19 Impact Global Prescription Dermatology Therapeutics Market Size
Table 11. Global Prescription Dermatology Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Prescription Dermatology Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Prescription Dermatology Therapeutics Market Growth Drivers
Table 14. Global Prescription Dermatology Therapeutics Market Restraints
Table 15. Global Prescription Dermatology Therapeutics Market Opportunities
Table 16. Global Prescription Dermatology Therapeutics Market Challenges
Table 17. By Players, Prescription Dermatology Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Prescription Dermatology Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Prescription Dermatology Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Prescription Dermatology Therapeutics Market
Table 21. Key Players Prescription Dermatology Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Prescription Dermatology Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Prescription Dermatology Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Prescription Dermatology Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Prescription Dermatology Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Pfizer Business Overview
Table 58. Pfizer Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer Prescription Dermatology Therapeutics Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. AbbVie Business Overview
Table 62. AbbVie Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. AbbVie Prescription Dermatology Therapeutics Product
Table 64. AbbVie Response to COVID-19 and Related Developments
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Johnson & Johnson Prescription Dermatology Therapeutics Product
Table 68. Johnson & Johnson Response to COVID-19 and Related Developments
Table 69. Novartis Business Overview
Table 70. Novartis Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Novartis Prescription Dermatology Therapeutics Product
Table 72. Novartis Response to COVID-19 and Related Developments
Table 73. Amgen Business Overview
Table 74. Amgen Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Amgen Prescription Dermatology Therapeutics Product
Table 76. Amgen Response to COVID-19 and Related Developments
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Eli Lilly Prescription Dermatology Therapeutics Product
Table 80. Eli Lilly Response to COVID-19 and Related Developments
Table 81. Celgene Business Overview
Table 82. Celgene Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Celgene Prescription Dermatology Therapeutics Product
Table 84. Celgene Response to COVID-19 and Related Developments
Table 85. LEO Pharma Business Overview
Table 86. LEO Pharma Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. LEO Pharma Prescription Dermatology Therapeutics Product
Table 88. LEO Pharma Response to COVID-19 and Related Developments
Table 89. Bausch Health Companies Business Overview
Table 90. Bausch Health Companies Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bausch Health Companies Prescription Dermatology Therapeutics Product
Table 92. Bausch Health Companies Response to COVID-19 and Related Developments
Table 93. Sun Pharmaceutical Business Overview
Table 94. Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sun Pharmaceutical Prescription Dermatology Therapeutics Product
Table 96. Sun Pharmaceutical Response to COVID-19 and Related Developments
Table 97. Aclaris Therapeutics Business Overview
Table 98. Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Aclaris Therapeutics Prescription Dermatology Therapeutics Product
Table 100. Aclaris Therapeutics Response to COVID-19 and Related Developments
List of FiguresFigure 1. Prescription Dermatology Therapeutics Product Picture
Figure 2. Prescription Dermatology Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Prescription Dermatology Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Prescription Dermatology Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Prescription Dermatology Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Prescription Dermatology Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Prescription Dermatology Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Prescription Dermatology Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Prescription Dermatology Therapeutics Market Size Market Share, 2019-2021